KEW Overview
- Year Founded
-
2009
- Status
-
Out of Business
- Employees
-
19
- Latest Deal Type
-
Out of Business
KEW General Information
Description
Operator of a genomic profiling company designed to revolutionize cancer care. The company provides therapeutic options based on an individual patient's tumor genetic profile for identifying genetic variants and matching them with targeted therapies in solid tumors, enabling molecular labs to expand oncology precision medicine programs for better treatment decisions and quality patient care.
Contact Information
Website
www.kewinc.comCorporate Office
- 303 Wyman Street
- Office Suite 349
- Waltham, MA 02451
- United States
Corporate Office
- 303 Wyman Street
- Office Suite 349
- Waltham, MA 02451
- United States
KEW Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Out of Business | 29-Dec-2023 | Completed | Out of Business | |||
| 3. Secondary Transaction - Private | 01-Nov-2020 | Completed | Generating Revenue | |||
| 2. Later Stage VC (Series B) | 12-Jan-2015 | $16.8M | $32.9M | Completed | Generating Revenue | |
| 1. Later Stage VC (Series A) | 24-Feb-2014 | $16.1M | $16.1M | Completed | Generating Revenue |
KEW Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series B | ||||||||
| Series A |
KEW Patents
KEW Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2012225666-A1 | Personalized medical management system, networks, and methods | Inactive | 04-Mar-2011 | ||
| EP-2681709-A2 | Personalized medical management system, networks, and methods | Inactive | 04-Mar-2011 | ||
| EP-2681709-A4 | Personalized medical management system, networks, and methods | Inactive | 04-Mar-2011 | ||
| US-20120231959-A1 | Personalized medical management system, networks, and methods | Inactive | 04-Mar-2011 | ||
| WO-2012122127-A2 | Personalized medical management system, networks, and methods | Inactive | 04-Mar-2011 | G16B50/00 |
KEW Signals
KEW Acquisitions (1)
KEW’s most recent deal was a Merger/Acquisition with Ship-Elec (Electrical Wholesalers). The deal was made on 13-Apr-2016.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Ship-Elec (Electrical Wholesalers) | 13-Apr-2016 | Merger/Acquisition | Distributors/Wholesale |
KEW FAQs
-
When was KEW founded?
KEW was founded in 2009.
-
Where is KEW headquartered?
KEW is headquartered in Waltham, MA.
-
What is the size of KEW?
KEW has 19 total employees.
-
What industry is KEW in?
KEW’s primary industry is Biotechnology.
-
Is KEW a private or public company?
KEW is a Private company.
-
What is KEW’s current revenue?
The current revenue for KEW is .
-
How much funding has KEW raised over time?
KEW has raised $32.9M.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process